Vitamin D deficiency co-exists in patients with COVID-19. At this time, dark skin color,
increased age, the presence of pre-existing illnesses and vitamin D deficiency are features …

Abstract Treatment of tuberculosis (TB) involves the administration of anti-mycobacterial
drugs for several months. The emergence of drug-resistant strains of Mycobacterium …

Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are
characterised by aberrant immunological responses leading to chronic inflammation without …

1, 25-dihydroxyvitamin D3 (1, 25 (OH) 2D3), the active form of vitamin D, is known to
regulate calcium and phosphorus metabolism, thus being a key-player in bone-formation …

The active metabolite of vitamin D, 1α, 25‐dihydroxyvitamin D3 [1, 25 (OH) 2D3], is involved
in calcium and phosphate metabolism and exerts a large number of biological effects …

Background Vitamin D was used to treat tuberculosis in the pre-antibiotic era, and its
metabolites induce antimycobacterial immunity in vitro. Clinical trials investigating the effect …

Calcidiol, the major circulating metabolite of vitamin D, supports induction of pleiotropic
antimicrobial responses in vitro. Vitamin D supplementation elevates circulating calcidiol …

Abstract Background Respiratory tract infections (RTIs) remain among of the most important
causes of morbidity and mortality among children. Several studies have associated vitamin …

Tuberculosis (TB), a chronic infectious disease of global importance, is facing the
emergence of drug-resistant strains with few new drugs to treat the infection. Pulmonary …

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading cause of
morbidity and mortality in humans worldwide. Currently, the standard treatment for TB …